Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing

About This Study

Ketamine is a medicine used in psychiatry for treatment-resistant depression. This study compares two ways of framing ketamine treatment: a psychedelic framing and a biomedical framing. The study will examine whether the framing affects depressive symptoms, treatment experience, tolerability, and longer-term outcomes.

Conditions Studied

Interventions

• •Psychedelic framing
• •Biomedical framing

Eligibility

Inclusion Criteria:

* Prescribed ketamine treatment for depression
* Able to understand study information and provide informed consent

Exclusion Criteria:

\- Patients who do not meet the inclusion criteria

Study Locations (1)